Immunological and virological profile of children with chilblain‐like lesions and SARS‐CoV‐2

L. Fertitta (1, 2) , A. Welfringer‐morin (1, 2) , A. Ouedrani (3) , L. Polivka (1, 2) , S. Chhun (3) , L. Chatenoud (3) , J. Fourgeaud (4) , S. Hadj‐rabia (1, 2, 5) , Sarah Temmam (6) , Marc Eloit (6) , I. Sermet‐gaudelus (7, 8, 9) , Christine Bodemer (1, 2, 5)

1 Service de Dermatologie [CHU-Necker]
2 MAGEC - Centre de référence national des Maladies Génétiques à Expression Cutanée - National Reference Center for Genodermatoses and Rare Skin Diseases
3 Laboratoire d'Immunologie [CHU Necker]
4 Laboratoire de Virologie [CHU-Necker]
5 Imagine - U1163 - Imagine - Institut des maladies génétiques (IHU)
6 Découverte de pathogènes – Pathogen discovery
7 Département de pneumologie [CHU-Necker]
8 Reference Center Rare Diseases: cystic fibrosis
9 INEM - UM 111 (UMR 8253 / U1151) - Institut Necker Enfants-Malades

The link between SARS‐CoV‐2 and the reported cutaneous manifestations has not been established. We assessed a possible correlation between the paediatric dermatological manifestations and the biological investigations, using for the first time 3 different SARS‐CoV‐2 tests.

Domains: Life Sciences [q-bio]; Human health and pathology; Infectious diseases; Life Sciences [q-bio]; Human health and pathology; Emerging diseases

L. Fertitta, A. Welfringer‐morin, A. Ouedrani, L. Polivka, S. Chhun, et al.. Immunological and virological profile of children with chilblain‐like lesions and SARS‐CoV‐2. Journal of the European Academy of Dermatology and Venereology, 2021, 35 (3), pp.e164-e167. ⟨10.1111/jdv.16972⟩. ⟨pasteur-03661208⟩